SEC Filings

Filing date	Description	Form	Filing Group	Issuer	View
View HTML 0001193125-18-344046.pdf 0001193125-18-344046.rtf 0001193125-18-344046.xls	Dec 07, 2018	An amendment to a SC 13D filing	SC 13D/A	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-18-030436.pdf 0000899243-18-030436.rtf	Dec 07, 2018	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-18-030438.pdf 0000899243-18-030438.rtf	Dec 07, 2018	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001564590-18-030604.pdf 0001564590-18-030604.rtf 0001564590-18-030604.xls	Dec 06, 2018	Report of unscheduled material events or corporate event	8-K	Current Reports	Eidos Therapeutics, Inc.
View HTML 0000899243-18-030324.pdf 0000899243-18-030324.rtf	Dec 06, 2018	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001564590-18-029055.pdf 0001564590-18-029055.rtf 0001564590-18-029055.xls	Nov 13, 2018	Report of unscheduled material events or corporate event	8-K	Current Reports	Eidos Therapeutics, Inc.
View HTML 0000899243-18-028482.pdf 0000899243-18-028482.rtf	Nov 07, 2018	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-18-028483.pdf 0000899243-18-028483.rtf	Nov 07, 2018	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-18-028484.pdf 0000899243-18-028484.rtf	Nov 07, 2018	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-18-028486.pdf 0000899243-18-028486.rtf	Nov 07, 2018	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.